Abstract:Targeted protein degradation (TPD) represents a potent chemical biology paradigm that leverages the cellular degradation machinery to pharmacologically eliminate specific proteins of interest. Although multiple E3 ligases have been discovered to facilitate TPD, there exists a compelling requirement to diversify the pool of E3 ligases available for such applications. This expansion will broaden the scope of potential protein targets, accommodating those with varying subcellular localizations and expression patterns. In this study, we describe a CRISPR-based transcriptional activation screen focused on human E3 ligases, with the goal of identifying E3 ligases that can facilitate heterobifunctional compound-mediated target degradation. This approach allows us to address the limitations associated with investigating candidate degrader molecules in specific cell lines that either lack or have low levels of the desired E3 ligases. Through this approach, we identified a candidate proteolysis-targeting chimera (PROTAC), 22-SLF, that induces the degradation of FKBP12 when the FBXO22 gene transcription is activated. 22-SLF induced the degradation of endogenous FKBP12 in a FBXO22-dependent manner across multiple cancer cell lines. Subsequent mechanistic investigations revealed that 22-SLF interacts with C227 and/or C228 in FBXO22 to achieve the target degradation. Finally, we demonstrated the versatility of FBXO22-based PROTACs by effectively degrading another endogenous protein BRD4. This study uncovers FBXO22 as an E3 ligase capable of supporting ligand-induced protein degradation through electrophilic PROTACs. The platform we have developed can readily be applied to elucidate protein degradation pathways by identifying E3 ligases that facilitate either small molecule-induced or endogenous protein degradation.

An in-cell approach to evaluate E3 ligases for use in targeted protein degradation.

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

ByeTAC: Bypassing an E3 Ligase for Targeted Protein Degradation

Targeted Protein Degradation: Current and Emerging Approaches for E3 Ligase Deconvolution

Exploring the target scope of KEAP1 E3 ligase-based PROTACs

Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, β-catenin, and FoxP3

Investigating Protein Degradability through Site-Specific Ubiquitin Ligase Recruitment

Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules

The cyclimids: Degron-inspired cereblon binders for targeted protein degradation

A CRISPR activation screen identifies FBXO22 as an E3 ligase supporting targeted protein degradation

Temporal and Spatial Characterization of CUL3KLHL20-driven Targeted Degradation of BET family, BRD Proteins by the Macrocycle-based Degrader BTR2004

Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation

Targeting UBE2C for Degradation by Bioprotacs Based on Bacterial E3 Ligase

IN SILICO DESIGN AND BINDING MECHANISM OF E3 LIGASE UBR1 RECRUITERS

Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras

Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2

Discovery of electrophilic degraders that exploit SNAr chemistry

Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox

A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation

Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues

Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16